Long Term Follow up of Scars Formation and Quality of Life Assessment Study
NCT ID: NCT01350700
Last Updated: 2017-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
148 participants
OBSERVATIONAL
2011-06-30
2011-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The burn wound, like any other wound, heals by the formation of scar at the injured site in order to replace the destroyed tissues. Scarring is not a static process, but rather a dynamic one, changing over time, especially during the first 24 months post-injury.
Scars and patients' quality of life from two treatment arms (DGD and SOC) will be compared in order to evaluate the long term influence of damaged skin removal and wound care techniques on scar formation and maturation.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients that were treated in MW2004-011-02 study with Debrase
Scars assessment & QOL
Scar assessment and quality of life questionnaires
Patients that were treated in MW2004-011-02 with SOC
Scars assessment & QOL
Scar assessment and quality of life questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scars assessment & QOL
Scar assessment and quality of life questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects must be willing and able to sign a written informed consent prior to study entry (by subject or by a guardian, when applicable).
4 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MediWound Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bio-technology company, MediWound Ltd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Koller, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Department Head of Burs and Reconstructive Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic of Burns and reconstructive surgery hospital
Košice, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MW2012-01-02
Identifier Type: -
Identifier Source: org_study_id